Results 121 to 130 of about 4,639 (191)

Sex-Specific Association of Rasagiline with Motor Progression in <i>GBA1</i>-Associated Parkinson's Disease. [PDF]

Life (Basel)
Saragani H, Henner R, Becker-Cohen M, Revel-Vilk S, Zimran A, Harari I, Eichel R, Yahalom G, Cohen ME.   +8 more
europepmc   +1 more source

Selective Neuronal Vulnerability to Alpha-Synuclein Pathology in Parkinson's Disease: A Critical Review of Mechanistic Rationale and Biomarker Stratification. [PDF]

Med Sci (Basel)
Livinț-Popa L, Nicolaie A, Mastaleru A, Socolov Ș, Mitrea M, Popescu G, Schreiner TG, Covali R, Cucu LE, Dima-Cozma LC, Cozma RS, Ciubotaru A, Olariu R, Ciurumelea CM, Borza LR, Vamanu A.   +15 more
europepmc   +1 more source

CRISPR screening in neurodegeneration and lysosomal biology: Uncovering disease mechanisms and genetic modifiers. [PDF]

Mol Genet Metab
Esmaeili H, Das S, Rytel K, Sidransky E, Chen Y.   +4 more
europepmc   +1 more source

Data from the ROPAD study corroborate an association between ITSN1 loss-of-function variants and Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Ganoza CA, Westenberger A, Paul JJ, Curado F, Somerville EN, Rennecke J, Bauer P, Beetz C.   +7 more
europepmc   +1 more source

Analyzing the 'bradykinesia complex' in GBA1-associated Parkinson's disease: A series of three cases. [PDF]

Clin Park Relat Disord
De Riggi M, Birreci D, Martini A, Aloisio S, Angelini L, Grandolfo AS, Bologna M.   +6 more
europepmc   +1 more source

Distinct Transcriptomic Signatures of HIV-1 Tat and gp120 Uncover Differential Neuroimmune Vulnerability in a <i>Gba1</i>-Deficient Synucleinopathy Model. [PDF]

Curr Issues Mol Biol
Lagni A, Lotti V, Diani E, Cecchetto R, Turrina S, Raniero D, Palmisano A, Mazzariol A, Gibellini D, Paolone G.   +9 more
europepmc   +1 more source

Return of genetic results to persons with Parkinson's disease: Blessing or foe? [PDF]

J Parkinsons Dis
Shiner T, Alcalay RN.
europepmc   +1 more source

Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implications. [PDF]

Lancet Neurol
Lange LM, Fang ZH, Makarious MB, Kuznetsov N, Atterling Brolin K, Ballard S, Bardien S, Doquenia ML, Heutink P, Houlden H, Iwaki H, Jasaityte S, Jones L, Junker J, Kaiyrzhanov R, Koretsky MJ, Kumar KR, Latin American Research Consortium on the Genetics of Parkinson's Disease (LARGE-PD), Leonard HL, Levine KS, Lim SY, Mencacci NE, Mohamed WMY, Nalls MA, Noyce AJ, Ojha R, Okubadejo NU, Ur Rehman S, Screven L, Shashkin C, Sopromadze S, Stafford EJ, Tan AH, Tan M, Tavadyan Z, Trinh J, Tserensodnom B, Valente EM, Vitale D, Zharkinbekova N, Lohmann K, Bandres-Ciga S, Blauwendraat C, Singleton AB, Morris HR, Klein C, Global Parkinson's Genetics Program (GP2).   +46 more
europepmc   +1 more source

Seed amplification of released alpha-synuclein strains reveals genotype-specific differences in Parkinson's disease neurons. [PDF]

Front Aging Neurosci
Chedid J, Tang Y, Law K, Thompson L, Gambin Y, Sierecki E, Dzamko N.   +6 more
europepmc   +1 more source